EMA Authorised: Riluzole Zentiva (riluzole) — Zentiva k.s.

View source ↗

Summary

The European Medicines Agency authorised Riluzole Zentiva (riluzole) by Zentiva k.s. for Amyotrophic Lateral Sclerosis on 15 May 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Riluzole Zentiva (riluzole)

Snippet

Status: Authorised. Therapeutic area: Amyotrophic Lateral Sclerosis. MAH: Zentiva k.s.. Decision date: 15/05/2025